5EUK
Cetuximab Fab in complex with F3H meditope variant
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU MICROMAX-007 HF |
Temperature [K] | 100 |
Detector technology | IMAGE PLATE |
Collection date | 2013-10-07 |
Detector | RIGAKU RAXIS IV++ |
Wavelength(s) | 1.5418 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 63.930, 82.060, 212.090 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 32.830 - 2.500 |
R-factor | 0.1746 |
Rwork | 0.171 |
R-free | 0.23370 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4gw1 |
RMSD bond length | 0.008 |
RMSD bond angle | 1.193 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | MOLREP |
Refinement software | PHENIX (dev_1426) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 32.830 | 2.560 |
High resolution limit [Å] | 2.500 | 2.500 |
Rmerge | 0.126 | 0.775 |
Number of reflections | 39428 | |
<I/σ(I)> | 11.3 | 1.8 |
Completeness [%] | 99.2 | 92.9 |
Redundancy | 3.8 | 3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 5.3 | 293 | 0.1 M citric acid, 0.1 M sodium phosphate dibasic, 0.4 M potassium phosphate dibasic, 1.6 M sodium phosphate monobasic |